// Biotech and Pharma Therapeutics Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts September 14, 2022 / Mounjaro / Tirzepatide / Type 2 Diabetes After snaring approval in May, Eli Lilly’s closely watched diabetes med tirzepatide—now christened...